Cargando…
Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study
BACKGROUND: Although carbon-ion radiotherapy (CIRT) may improve outcome for patients with locoregionally recurrent nasopharyngeal carcinoma (LR-NPC), local progression still remains one of the major failure patterns. This suggests an unmet need of markers for predicting disease control after re-irra...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761158/ https://www.ncbi.nlm.nih.gov/pubmed/36544650 http://dx.doi.org/10.21037/atm-20-5214 |
_version_ | 1784852647515258880 |
---|---|
author | Hu, Jiyi Yang, Zhongyi Gao, Jing Hu, Weixu Yang, Jing Qiu, Xianxin Ma, Guang Kong, Lin Lu, Jiade J. |
author_facet | Hu, Jiyi Yang, Zhongyi Gao, Jing Hu, Weixu Yang, Jing Qiu, Xianxin Ma, Guang Kong, Lin Lu, Jiade J. |
author_sort | Hu, Jiyi |
collection | PubMed |
description | BACKGROUND: Although carbon-ion radiotherapy (CIRT) may improve outcome for patients with locoregionally recurrent nasopharyngeal carcinoma (LR-NPC), local progression still remains one of the major failure patterns. This suggests an unmet need of markers for predicting disease control after re-irradiation and potentially guiding tailored treatment. The purpose of this study was to explore the predictive value of pre-treatment 3’-deoxy-3’-[(18)F]fluorothymidine (FLT)-positron emission tomography (PET) for patients with locally advanced LR-NPC. METHODS: In this retrospective analysis, LR-NPC patients with locally advanced stage (stage III/IV) who received pre-treatment FLT-PET between June, 2015, and August, 2017, were retrospective reviewed and included in this study. OS and local progression-free survival (LPFS) were calculated using the Kaplan-Meier method. Univariable and multivariable Cox regression analyses of LPFS were performed. FLT-derived parameters, including SUV(max), metabolic tumor volume (MTV), and total lesion thymidine (TLT) were examined. The relationship between FLT-derived parameters and mucosal necrosis was tested by the Wilcoxon test. RESULTS: A total of 27 patients with a median follow-up of 31.3 months were included in this analysis. The 2-year OS and LPFS rates were 85.2% and 47.9%, respectively. In multivariable analysis, except for TLT-40% (P=0.059), all pre-treatment MTVs (P=0.040 for MTV-40%; P=0.021 for MTV-50%; P=0.026 for MTV-60%) and TLTs (P=0.043 for TLT-50%; P=0.048 for TLT-60%) were significantly related to LPFS. Moreover, MTVs and TLTs with various boundaries (except for MTV-40%) were also associated with the development of mucosal necrosis after CIRT. CONCLUSIONS: In the current study, a significant association between pre-treatment FLT-PET and LPFS was observed in patients with locally advanced LR-NPC. Further investigations are warranted to confirm the predictive role of FLT-PET. |
format | Online Article Text |
id | pubmed-9761158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-97611582022-12-20 Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study Hu, Jiyi Yang, Zhongyi Gao, Jing Hu, Weixu Yang, Jing Qiu, Xianxin Ma, Guang Kong, Lin Lu, Jiade J. Ann Transl Med Original Article BACKGROUND: Although carbon-ion radiotherapy (CIRT) may improve outcome for patients with locoregionally recurrent nasopharyngeal carcinoma (LR-NPC), local progression still remains one of the major failure patterns. This suggests an unmet need of markers for predicting disease control after re-irradiation and potentially guiding tailored treatment. The purpose of this study was to explore the predictive value of pre-treatment 3’-deoxy-3’-[(18)F]fluorothymidine (FLT)-positron emission tomography (PET) for patients with locally advanced LR-NPC. METHODS: In this retrospective analysis, LR-NPC patients with locally advanced stage (stage III/IV) who received pre-treatment FLT-PET between June, 2015, and August, 2017, were retrospective reviewed and included in this study. OS and local progression-free survival (LPFS) were calculated using the Kaplan-Meier method. Univariable and multivariable Cox regression analyses of LPFS were performed. FLT-derived parameters, including SUV(max), metabolic tumor volume (MTV), and total lesion thymidine (TLT) were examined. The relationship between FLT-derived parameters and mucosal necrosis was tested by the Wilcoxon test. RESULTS: A total of 27 patients with a median follow-up of 31.3 months were included in this analysis. The 2-year OS and LPFS rates were 85.2% and 47.9%, respectively. In multivariable analysis, except for TLT-40% (P=0.059), all pre-treatment MTVs (P=0.040 for MTV-40%; P=0.021 for MTV-50%; P=0.026 for MTV-60%) and TLTs (P=0.043 for TLT-50%; P=0.048 for TLT-60%) were significantly related to LPFS. Moreover, MTVs and TLTs with various boundaries (except for MTV-40%) were also associated with the development of mucosal necrosis after CIRT. CONCLUSIONS: In the current study, a significant association between pre-treatment FLT-PET and LPFS was observed in patients with locally advanced LR-NPC. Further investigations are warranted to confirm the predictive role of FLT-PET. AME Publishing Company 2022-11 /pmc/articles/PMC9761158/ /pubmed/36544650 http://dx.doi.org/10.21037/atm-20-5214 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Hu, Jiyi Yang, Zhongyi Gao, Jing Hu, Weixu Yang, Jing Qiu, Xianxin Ma, Guang Kong, Lin Lu, Jiade J. Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title | Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title_full | Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title_fullStr | Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title_full_unstemmed | Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title_short | Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
title_sort | pre-treatment flt-pet parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761158/ https://www.ncbi.nlm.nih.gov/pubmed/36544650 http://dx.doi.org/10.21037/atm-20-5214 |
work_keys_str_mv | AT hujiyi pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT yangzhongyi pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT gaojing pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT huweixu pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT yangjing pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT qiuxianxin pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT maguang pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT konglin pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy AT lujiadej pretreatmentfltpetparametersasaprognostictoolforpatientswithlocallyadvancedrecurrentnasopharyngealcarcinomasalvagedbycarbonionradiotherapyapilotstudy |